| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Marc Lipsitch | Q28322531 |
| P2093 | author name string | George R Siber | |
| P2860 | cites work | Vaccine protection against Staphylococcus aureus pneumonia | Q24650703 |
| Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field | Q26786281 | ||
| Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge | Q26796265 | ||
| Staphylococcal manipulation of host immune responses | Q26798461 | ||
| Where does a Staphylococcus aureus vaccine stand? | Q26828726 | ||
| Human monoclonal antibody-based therapy in the treatment of invasive candidiasis | Q26864291 | ||
| Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine | Q27008338 | ||
| Origin and proliferation of multiple-drug resistance in bacterial pathogens | Q27023284 | ||
| Haemophilus influenzae disease in children in India: a hospital perspective. | Q50635134 | ||
| Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. | Q53798907 | ||
| Incremental Increase in Fitness Cost with Increased β‐Lactam Resistance in Pneumococci Evaluated by Competition in an Infant Rat Nasal Colonization Model | Q56762383 | ||
| Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae | Q64130946 | ||
| Appropriate use of antibiotics for URIs in children: Part II. Cough, pharyngitis and the common cold. The Pediatric URI Consensus Team | Q64132577 | ||
| Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia | Q77643486 | ||
| Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice | Q82714641 | ||
| Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump | Q84977137 | ||
| FdeC, a Novel Broadly Conserved Escherichia coli Adhesin Eliciting Protection against Urinary Tract Infections | Q27678478 | ||
| Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011 | Q28005532 | ||
| Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study | Q28005554 | ||
| Herd immunity: history, theory, practice | Q28252852 | ||
| Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA | Q28475821 | ||
| Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains | Q28485487 | ||
| Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance | Q28534880 | ||
| Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. | Q30448313 | ||
| NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. | Q30528889 | ||
| Bacterial vaccines and antibiotic resistance | Q33667565 | ||
| Outpatient antibiotic prescribing in the United States: 2000 to 2010. | Q33790880 | ||
| Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli | Q33927393 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| Reverse vaccinology | Q34069770 | ||
| Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance | Q34163308 | ||
| Serotype replacement in disease after pneumococcal vaccination | Q34178363 | ||
| A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers | Q34271496 | ||
| Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax | Q34334451 | ||
| Antibiotic resistance-the need for global solutions | Q34386251 | ||
| Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model | Q34387963 | ||
| Influence of anti-FloR antibody on florfenicol accumulation in florfenicol-resistant Escherichia coli and enzyme-linked immunosorbent assay for detection of florfenicol-resistant E. coli isolates | Q34430578 | ||
| Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. | Q34671882 | ||
| The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem | Q34984415 | ||
| Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites | Q35004396 | ||
| Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation | Q35188450 | ||
| Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now. | Q35548019 | ||
| Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci | Q35583504 | ||
| Problems and dilemmas of antimicrobial resistance | Q35655673 | ||
| Respiratory fluoroquinolone use and influenza | Q35673288 | ||
| Antibacterial monoclonal antibodies: the next generation? | Q35753866 | ||
| Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity | Q35844906 | ||
| MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model | Q35859999 | ||
| A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium | Q35925789 | ||
| MRSA virulence and spread. | Q36236532 | ||
| Strategies for achieving global collective action on antimicrobial resistance | Q36347030 | ||
| Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. | Q36384449 | ||
| Improving the estimation of influenza-related mortality over a seasonal baseline | Q36450948 | ||
| A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2 | Q36472741 | ||
| Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales | Q36570874 | ||
| Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine | Q36603519 | ||
| Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance | Q36926619 | ||
| Population genomics of post-vaccine changes in pneumococcal epidemiology. | Q37051002 | ||
| Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity | Q37103959 | ||
| Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States | Q37187505 | ||
| The population and evolutionary dynamics of homologous gene recombination in bacterial populations | Q37279482 | ||
| Global population structure and evolution of Bordetella pertussis and their relationship with vaccination | Q37714873 | ||
| Candida albicans Als3, a multifunctional adhesin and invasin | Q37813335 | ||
| Clostridium difficile: development of a novel candidate vaccine | Q38017389 | ||
| A review of the effect of immunization programs on antimicrobial utilization. | Q38039794 | ||
| Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects". | Q38102491 | ||
| Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach. | Q38354675 | ||
| Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. | Q38396086 | ||
| Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial | Q38412044 | ||
| Access to effective antimicrobials: a worldwide challenge | Q38646928 | ||
| A multifunctional bispecific antibody protects against Pseudomonas aeruginosa | Q38940907 | ||
| Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model | Q40764996 | ||
| The kinetics of conjugative plasmid transmission: Fit of a simple mass action model | Q41055017 | ||
| Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae | Q41851462 | ||
| Pertactin-negative variants of Bordetella pertussis in the United States | Q42365877 | ||
| The effect of universal influenza immunization on antibiotic prescriptions: an ecological study | Q43989615 | ||
| Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection. | Q44367885 | ||
| Inappropriate antibiotic prescribing in managed care subjects with influenza. | Q44594985 | ||
| WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. | Q45341636 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| antibiotic resistance | Q380775 | ||
| bacterial infectious disease | Q727028 | ||
| bacterial multiple drug resistance | Q2878482 | ||
| antimicrobial resistance | Q63391344 | ||
| physiological phenomenon | Q66615932 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e00428-16 | |
| P577 | publication date | 2016-06-07 | |
| P1433 | published in | mBio | Q15817061 |
| P1476 | title | How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem? | |
| P478 | volume | 7 |
| Q57789702 | Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity and Staphylococcus aureus Fitness in Infection Models |
| Q93111509 | Analysis of isolates from Bangladesh highlights multiple ways to carry resistance genes in Salmonella Typhi |
| Q37691079 | Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology |
| Q60301815 | Antimicrobial resistance and the role of vaccines |
| Q92417066 | Antimicrobial use in an Indonesian community cohort 0-18 months of age |
| Q94592014 | Childhood vaccines and antibiotic use in low- and middle-income countries |
| Q59791499 | Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract |
| Q64983927 | Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms. |
| Q58762161 | Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa |
| Q60919125 | Drivers, alternatives, knowledge, and perceptions towards antimicrobial use among Tennessee beef cattle producers: a qualitative study |
| Q90583429 | Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review |
| Q64124275 | Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic data |
| Q55223424 | Education in Vaccinology: An Important Tool for Strengthening Global Health. |
| Q91248946 | Efficacy of inactivated influenza vaccines in young children |
| Q90595405 | Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora |
| Q90135534 | Expression of a novel class of bacterial Ig-like proteins is required for IncHI plasmid conjugation |
| Q56380004 | Healthcare-associated infections: potential for prevention through vaccination |
| Q53478412 | Hopes and challenges for the common cold. |
| Q90039464 | Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaoundé, Cameroon, in the Post-Vaccine Era |
| Q47105309 | Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae |
| Q36309162 | In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli |
| Q90248934 | Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60 |
| Q92296556 | Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature |
| Q90779193 | Meeting report: Global vaccine and immunization research forum, 2018 |
| Q55666271 | Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis. |
| Q37724389 | Penicillin's Discovery and Antibiotic Resistance: Lessons for the Future? |
| Q64091938 | Population-level mathematical modeling of antimicrobial resistance: a systematic review |
| Q54215595 | Potential impact of influenza vaccine roll-out on antibiotic use in Africa. |
| Q53701548 | Potential targets for next generation anti-microbial glycoconjugate vaccines. |
| Q94956830 | Preparing to introduce new maternal immunizations in low- and lower-middle-income countries: A report from the Bill & Melinda Gates Foundation convening "Allies in Maternal and Newborn Care"; May 3-4, 2018 |
| Q53437644 | Prioritizing a One Health Approach in the Immediate Fight Against Antimicrobial Resistance. |
| Q28955396 | Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016 |
| Q50034272 | Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. |
| Q92968788 | Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses |
| Q57796116 | The return of Pfeiffer’s bacillus: Rising incidence of ampicillin resistance in Haemophilus influenzae |
| Q50120750 | The role of vaccines in preventing bacterial antimicrobial resistance |
| Q60301816 | Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR |
| Q89022489 | Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure |
| Q47606815 | Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance |
| Q54963907 | Vaccination programs for older adults in an era of demographic change. |
| Q50057450 | Vaccination to reduce antimicrobial resistance |
| Q92564603 | Vaccine Evolution and Its Application to Fight Modern Threats |
| Q90204201 | Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies |
| Q56892169 | Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs |
| Q51219718 | Why does drug resistance readily evolve but vaccine resistance does not? |
| Q60301818 | Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance |
| Q93344976 | [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] |
| Q96230739 | [Vaccine of the future] |
Search more.